CA2479514C - Tumor imaging compounds - Google Patents
Tumor imaging compounds Download PDFInfo
- Publication number
- CA2479514C CA2479514C CA2479514A CA2479514A CA2479514C CA 2479514 C CA2479514 C CA 2479514C CA 2479514 A CA2479514 A CA 2479514A CA 2479514 A CA2479514 A CA 2479514A CA 2479514 C CA2479514 C CA 2479514C
- Authority
- CA
- Canada
- Prior art keywords
- compound
- uptake
- tumor
- amino acid
- compounds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
- C07F13/005—Compounds without a metal-carbon linkage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
- A61K51/0487—Metallocenes, i.e. complexes based on a radioactive metal complexed by two cyclopentadienyl anions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Optics & Photonics (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US37712402P | 2002-04-30 | 2002-04-30 | |
| US60/377,124 | 2002-04-30 | ||
| PCT/US2003/012748 WO2003093412A2 (en) | 2002-04-30 | 2003-04-24 | Tumor imaging compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2479514A1 CA2479514A1 (en) | 2003-11-13 |
| CA2479514C true CA2479514C (en) | 2011-07-26 |
Family
ID=29401448
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2479514A Expired - Fee Related CA2479514C (en) | 2002-04-30 | 2003-04-24 | Tumor imaging compounds |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US7544715B2 (https=) |
| EP (1) | EP1499584B1 (https=) |
| JP (2) | JP4611017B2 (https=) |
| KR (1) | KR100745445B1 (https=) |
| CN (2) | CN101041674A (https=) |
| AT (1) | ATE478041T1 (https=) |
| AU (1) | AU2003231758B2 (https=) |
| CA (1) | CA2479514C (https=) |
| DE (1) | DE60333830D1 (https=) |
| DK (1) | DK1499584T3 (https=) |
| ES (1) | ES2349528T3 (https=) |
| NZ (1) | NZ535333A (https=) |
| WO (1) | WO2003093412A2 (https=) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060292073A1 (en) * | 2005-06-23 | 2006-12-28 | Emory University | Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging |
| US7837982B2 (en) | 2005-06-23 | 2010-11-23 | Emory University | Imaging agents |
| WO2007030571A2 (en) * | 2005-09-06 | 2007-03-15 | Molecular Image Inc. | Identification of targets and development of reagents for testing and molecular imaging of human disease |
| WO2007137135A2 (en) * | 2006-05-18 | 2007-11-29 | The Regents Of The University Of California | Rotenone analogs: method of preparation and use |
| AU2007202205A1 (en) * | 2006-05-18 | 2007-12-06 | Deere & Company | Multi-prong conversion tine for a harvester reel |
| WO2009045535A2 (en) * | 2007-10-04 | 2009-04-09 | Sloan-Kettering Institute For Cancer Research | Fluorine-18 derivative of dasatinib and uses thereof |
| US8246752B2 (en) | 2008-01-25 | 2012-08-21 | Clear Catheter Systems, Inc. | Methods and devices to clear obstructions from medical tubes |
| US20110033382A1 (en) | 2008-04-14 | 2011-02-10 | Emory University | Imaging Agents |
| US8722014B2 (en) * | 2009-05-01 | 2014-05-13 | Washington University | 1 H-[1, 2, 3] triazole substituted amino acids and uses thereof |
| CN101954097B (zh) * | 2009-07-14 | 2014-06-04 | 北京师范大学 | 新型18f标记取代苯并咪唑类化合物及其制备方法和制备肿瘤pet显像剂中的应用 |
| AU2011268129A1 (en) * | 2010-06-18 | 2013-01-10 | The Regents Of The University Of California | Isotopic labeling for the measurement of global protein levels and turnover in vivo |
| EP2632495A2 (en) | 2010-10-28 | 2013-09-04 | GE Healthcare UK Limited | Stabilisation of radiopharmaceutical precursors |
| CA3034757A1 (en) | 2016-08-23 | 2018-03-01 | Simon Fraser University | 18f labeled amino acids, derivatives thereof and method of making same |
| EP3293167A1 (en) * | 2016-09-09 | 2018-03-14 | Université Catholique De Louvain | [18f]-labelled lactate derivative as pet radiotracer |
| CA3083111C (en) * | 2017-11-21 | 2022-09-20 | Solvex Limited Liability Company | Preparation for magnetic resonance diagnostics for oncological diseases, comprising deuterated 2-amino-2-methylpropionic acid and/or 2-(n-methylamino)-2-methylpropionic acid, and diagnostic method using said preparation |
| EP3892612B1 (en) * | 2018-12-05 | 2025-05-14 | Otsuka Chemical Co., Ltd. | Method for producing organic tellurium compound and method for producing vinyl polymer |
| CN114163343A (zh) * | 2021-12-10 | 2022-03-11 | 许昌学院 | 含氟氨基酸及衍生物含氟多肽的制备方法以及应用 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3855208A (en) * | 1971-05-24 | 1974-12-17 | Becton Dickinson Co | Derivatives of digoxigenin |
| US4325961A (en) * | 1977-06-01 | 1982-04-20 | Merck & Co., Inc. | Fluorinated amino acids |
| US4695588A (en) * | 1977-06-01 | 1987-09-22 | Merck & Co., Inc. | Fluorinated amino acids |
| US4743691A (en) * | 1977-07-11 | 1988-05-10 | Merrell Dow France Et Cie | 2-halomethyl derivatives of 2-amino acids |
| US4483870A (en) * | 1978-07-24 | 1984-11-20 | Merck & Co., Inc. | α-Difluoromethyl amino acids and hypertension treating compositions thereof |
| US4390517A (en) * | 1979-12-19 | 1983-06-28 | New England Nuclear Corporation | Method, composition and kit for stabilizing radiolabeled compounds |
| US4358434A (en) * | 1979-12-19 | 1982-11-09 | New England Nuclear Corporation | Method, composition and kit for stabilizing radiolabeled compounds |
| US4942231A (en) * | 1984-05-24 | 1990-07-17 | Mallinckrodt, Inc. | Method of preparing a chlorinated, brominated, radio-brominated, iodinated and/or radioiodinated aromatic or heteroaromatic compound |
| US4760091A (en) * | 1985-10-01 | 1988-07-26 | The Dow Chemical Company | Method of controlling phytopathogenic fungus |
| US5227467A (en) * | 1987-08-03 | 1993-07-13 | Merck & Co., Inc. | Immunosuppressive fluorinated cyclosporin analogs |
| US5116599A (en) * | 1989-07-31 | 1992-05-26 | Johns Hopkins Univ. | Perfluoro-t-butyl-containing compounds for use in fluorine-19 nmr and/or mri |
| ZA907743B (en) * | 1989-10-03 | 1991-07-31 | Merrell Dow Pharma | Radiolabeled anticoagulant peptides |
| US5128118A (en) * | 1990-08-09 | 1992-07-07 | Research Triangle Institute | Cocaine receptor binding ligands |
| US5310912A (en) * | 1992-02-25 | 1994-05-10 | Research Biochemicals Limited Partnership | Iodinated neuroprobe for mapping monoamine reuptake sites |
| US5698179A (en) * | 1992-02-25 | 1997-12-16 | Neuro Imaging Technologies, Llc | Iodinated neuroprobe for mapping monoamine reuptake sites |
| US5637759A (en) * | 1992-07-30 | 1997-06-10 | The Regents Of The University Of California | Metal-ligating amino acid derivatives for MRI and for peptide synthesis |
| US5493026A (en) * | 1993-10-25 | 1996-02-20 | Organix, Inc. | Substituted 2-carboxyalkyl-3-(fluorophenyl)-8-(3-halopropen-2-yl) nortropanes and their use as imaging for agents for neurodegenerative disorders |
| US5808146A (en) * | 1995-11-09 | 1998-09-15 | Emory University | Amino acid analogs for tumor imaging |
| FR2748475B1 (fr) | 1996-05-10 | 1999-04-16 | Cis Bio Int | Derives du tropane utilisables en particulier pour la detection in vivo des transporteurs de la dopamine |
| US6344179B1 (en) * | 1999-04-22 | 2002-02-05 | Emory University | Fluoralkenyl nortropanes |
| US6399042B1 (en) * | 1999-04-26 | 2002-06-04 | Emory University | 4-fluoroalkyl-3-halophenyl nortropanes |
| US6843979B2 (en) * | 1999-04-26 | 2005-01-18 | Emory University | 4-haloethenylphenyl tropane:serotonin transporter imaging agents |
| US6933042B2 (en) * | 2003-07-30 | 2005-08-23 | Hitachi Global Storage Technologies Netherlands B.V. | Ballistic GMR structure using nanoconstruction in self pinned layers |
-
2003
- 2003-04-24 DE DE60333830T patent/DE60333830D1/de not_active Expired - Lifetime
- 2003-04-24 CN CNA2007100876699A patent/CN101041674A/zh active Pending
- 2003-04-24 US US10/507,221 patent/US7544715B2/en not_active Expired - Lifetime
- 2003-04-24 ES ES03747599T patent/ES2349528T3/es not_active Expired - Lifetime
- 2003-04-24 EP EP03747599A patent/EP1499584B1/en not_active Expired - Lifetime
- 2003-04-24 NZ NZ535333A patent/NZ535333A/en not_active IP Right Cessation
- 2003-04-24 KR KR1020047014825A patent/KR100745445B1/ko not_active Expired - Fee Related
- 2003-04-24 JP JP2004501548A patent/JP4611017B2/ja not_active Expired - Fee Related
- 2003-04-24 DK DK03747599.3T patent/DK1499584T3/da active
- 2003-04-24 CN CNB038098733A patent/CN1313436C/zh not_active Expired - Lifetime
- 2003-04-24 CA CA2479514A patent/CA2479514C/en not_active Expired - Fee Related
- 2003-04-24 WO PCT/US2003/012748 patent/WO2003093412A2/en not_active Ceased
- 2003-04-24 AU AU2003231758A patent/AU2003231758B2/en not_active Ceased
- 2003-04-24 AT AT03747599T patent/ATE478041T1/de active
-
2009
- 2009-02-26 JP JP2009044923A patent/JP2009149678A/ja active Pending
- 2009-05-12 US US12/464,226 patent/US7989649B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050005425A (ko) | 2005-01-13 |
| AU2003231758B2 (en) | 2009-10-22 |
| US7544715B2 (en) | 2009-06-09 |
| US20090240041A1 (en) | 2009-09-24 |
| HK1073296A1 (en) | 2005-09-30 |
| JP2005523941A (ja) | 2005-08-11 |
| US7989649B2 (en) | 2011-08-02 |
| ATE478041T1 (de) | 2010-09-15 |
| EP1499584A2 (en) | 2005-01-26 |
| EP1499584B1 (en) | 2010-08-18 |
| CN1313436C (zh) | 2007-05-02 |
| WO2003093412A3 (en) | 2004-04-01 |
| JP4611017B2 (ja) | 2011-01-12 |
| DK1499584T3 (da) | 2010-09-20 |
| CA2479514A1 (en) | 2003-11-13 |
| CN1649828A (zh) | 2005-08-03 |
| EP1499584A4 (en) | 2007-08-15 |
| ES2349528T3 (es) | 2011-01-04 |
| CN101041674A (zh) | 2007-09-26 |
| NZ535333A (en) | 2007-02-23 |
| US20050192458A1 (en) | 2005-09-01 |
| JP2009149678A (ja) | 2009-07-09 |
| DE60333830D1 (de) | 2010-09-30 |
| AU2003231758A1 (en) | 2003-11-17 |
| WO2003093412A2 (en) | 2003-11-13 |
| KR100745445B1 (ko) | 2007-08-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7989649B2 (en) | Tumor imaging compounds | |
| CA2612187C (en) | Stereoselective synthesis of amino acid analogs for tumor imaging | |
| US8435493B2 (en) | Imaging agents | |
| ES2281927T3 (es) | Complejantes tetraaza- o n2s2-, y su uso en radiodiagnostico o en radioterapia. | |
| US5539138A (en) | High affinity chelates containing isothiocyanate groups, useful for coupling with peptides and proteins | |
| HK1073296B (en) | Tumor imaging compounds | |
| KR102269315B1 (ko) | 전립선 암의 영상 또는 치료를 위한 동위원소 표지 화합물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20150424 |